These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

17 related articles for article (PubMed ID: 18671027)

  • 1. Virus-containing migrasomes enable poxviruses to evade tecovirimat/ST-246 treatment.
    Zhao W; Tang X; Zhang L
    J Infect; 2024 Feb; 88(2):203-205. PubMed ID: 38103650
    [No Abstract]   [Full Text] [Related]  

  • 2. Pathogenicity and immunogenicity of mynah pox virus in chickens and bobwhite quail.
    Reed WM; Schrader DL
    Poult Sci; 1989 May; 68(5):631-8. PubMed ID: 2547209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of a commercial quail pox vaccine (Bio-Pox Q) for the control of "variant" fowl poxvirus infections.
    Fatunmbi OO; Reed WM
    Avian Dis; 1996; 40(4):792-7. PubMed ID: 8980808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Avian pox: infection and immunity with quail, psittacine, fowl, and pigeon pox viruses.
    Winterfield RW; Reed W
    Poult Sci; 1985 Jan; 64(1):65-70. PubMed ID: 2579373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infection and immunity with a virus isolate from turkeys.
    Winterfield RW; Reed WM; Thacker HL
    Poult Sci; 1985 Nov; 64(11):2076-80. PubMed ID: 2999743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Failure of a recombinant fowl poxvirus vaccine containing an avian influenza hemagglutinin gene to provide consistent protection against influenza in chickens preimmunized with a fowl pox vaccine.
    Swayne DE; Beck JR; Kinney N
    Avian Dis; 2000; 44(1):132-7. PubMed ID: 10737653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenicity and immunological relationship of quail and mynah poxviruses to fowl and pigeon poxviruses.
    Reed WM; Fatunmbi OO
    Avian Pathol; 1993 Jun; 22(2):395-400. PubMed ID: 18671027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospects and limitations of recombinant poxviruses for prostate cancer immunotherapy.
    Hwang C; Sanda MG
    Curr Opin Mol Ther; 1999 Aug; 1(4):471-9. PubMed ID: 11713762
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 10.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 1.